Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Carboplatin vs M-CAVI in Advanced Urothelial Cancer
NCT00014274Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jan 2001
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of gemcitabine in urothelial carcinoma (UC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jan 2001; status: completed.
02
Drugs
gemcitabine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00014274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014274.